Vaccinia recombinants expressing secreted and transmembrane forms of breast cancer-associated epithelial tumour antigen (ETA)

Vaccine

Volumn 9, Issue 9, 1991, Pages 618-626

  Hareuveni, Mara ^a   Wreschner, Daniel H ^b   Kieny, Marie Paule ^c   Dott, Karin ^c   Gautier, Claudie ^a   Tomasetto, Catherine ^a   Keydar, Iafa ^b   Chambon, Pierre ^a   Lathe, Richard ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b TEL AVIV UNIVERSITY   (Israel)

^c TRANSGENE S A   (France)

Author keywords

breast cancer; epithelial tumour antigen; vaccine; Vaccinia

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR ANTIGEN; VACCINE;

ARTICLE; BREAST CANCER; HUMAN; HUMAN CELL; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANTIGENS, NEOPLASM; BASE SEQUENCE; BREAST NEOPLASMS; CA-15-3 ANTIGEN; FEMALE; HUMAN; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; RECOMBINATION, GENETIC; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; VACCINES, SYNTHETIC; VACCINIA VIRUS;

EID: 0025856506     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(91)90185-9     Document Type: Article

References (39)

1. Structure and function of the CA antigen
2. Complexity of expression of antigenic determinants recognised by monoclonal antibodies HMFG-1 and HMFG-2 in normal and malignant human mammary epithelial cells
3. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin
4. Variability in surface expression of human breast epithelial cells cultured from normal breast, normal tissue peripheral to breast carcinomas, and breast carcinomas
5. Monoclonal antibodies against human milk fat globule membranes detecting differentiating antigens of the mammary gland and its tumour
6. Isolation and properties of a human pancreatic adenocarcinoma-associated antigen
7. Effects of maturational agents on expression and secretion of two partially characterized high molecular weight milk-related glycoproteins in MCF-7 breast carcinoma cells
8. Analysis of a human tumour-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3
9. Epitopes with diagnostic and prognostic significance co-expressed on a human breast carcinoma-associated antigen
10. Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens
11. H23 monoclonal antibody recognizes a breast tumor associated antigen: clinical and molecular studies
12. A transcribed gene, containing a variable number of tandem repeats, codes for a human epithelial tumor antigen
13. Human epithelial tumor antigen cDNA sequences; differential splicing may generate multiple protein forms
14. Isolation and characterization of an expressed hypervariable gene coding for a breast cancer associated antigen
15. Molecular aspects of mucins
16. A highly immunogenic region of a mucin polymorphic epithelial antigen expressed by carcinomas is made up of tandem repeats
17. Polymorphic epithelial mucin and CA125-bearing glycoprotein in basic and applied carcinoma research
18. Mucins in breast cancer: recent immunological advances
19. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma associated antigen
20. Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium
21. Molecular cloning and expression of the human tumor-associated polymorphic epithelial mucin, PEM
22. Vaccinia virus expression vectors
23. T lymphocyte priming and protection against friend leukemia by vaccinia-retrovirus env gene recombinant
24. Tumour prevention and rejection with recombinant vaccinia
25. Vaccinia recombinants expressing early bovine papilloma virus (BPV1) proteins: retardation of BPV1 tumour development
26. Tumour markers — where do we go from here?
27. Recombinant vaccinia vaccine against the human melanoma antigen p97 for use in immunotherapy
28. Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector
29. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumour RNA
30. Plasmid and bacteriophage vectors for excision of intact inserts
31. Expression of rabies virus glycoprotein from a recombinant vaccinia virus
32. AIDS virus env protein expressed from a recombinant vaccinia virus
33. New generation of rabies vaccine; vaccinia-rabies glycoprotein recombinant virus
34. Improved antigenicity of the HIV1 env protein by cleavage site removal
35. Cell-free synthesis of biologically active heat-stable enterotoxin of Escherichia coli from a cloned gene
36. Epidermal growth factor and oncogenes induce transcription of the same cellular RNA as in rat fibroblasts
37. High-frequency homologous recombination in vaccinia virus DNA
38. Vaccination against tumor cells expressing breast cancer epithelial tumor antigen